| 000 | 01263 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513023030.0 | ||
| 264 | 0 | _c19800926 | |
| 008 | 198009s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1038/clpt.1980.123 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChau, N P | |
| 245 | 0 | 0 |
_aPrazosin kinetics in essential hypertension. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cJul 1980 |
||
| 300 |
_a6-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAbsorption |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrazosin _xadministration & dosage |
| 650 | 0 | 4 |
_aQuinazolines _xmetabolism |
| 700 | 1 | _aFlouvat, B L | |
| 700 | 1 | _aLe Roux, E | |
| 700 | 1 | _aSafar, M E | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 28 _gno. 1 _gp. 6-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.1980.123 _zAvailable from publisher's website |
| 999 |
_c7388764 _d7388764 |
||